Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. - Wikidata - awgldk - TriplyDB

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

http://www.wikidata.org/entity/Q48878233

about

Erythropoietin Pathway: A Potential Target for the Treatment of Depression Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice Pharmacological approaches to the challenge of treatment-resistant depression Ketamine, sleep, and depression: current status and new questions Practical clinical trials in psychopharmacology: a systematic review Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical review Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression.Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.MAOIs - does the evidence warrant their resurrection?Beyond serotonin: newer antidepressants in the future.Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.Robust and sustained effect of ketamine infusions coadministered with conventional antidepressants in a patient with refractory major depression.Evidence-based treatment for depressive disorder.Polypharmacy or medication washout: an old tool revisited Toward a neuroimaging treatment selection biomarker for major depressive disorder.Depression treatment in patients with general medical conditions: results from the CO-MED trial.Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients Are antidepressants effective in the acute and long-term treatment of depression? Sic et Non Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients Is there anything really novel on the antidepressant horizon?Multi-modality: a new approach for the treatment of major depressive disorder.Ketamine as a novel antidepressant: from synapse to behavior.A review of antidepressant therapy in primary care: current practices and future directions.The Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver.

P2860

Q26750850-585BB8D3-09C7-4AC3-86D6-FFA261C666D0 Q26782997-7E630B9B-B64E-4E5C-BDB1-DB989068CFA1 Q26797416-4D5C7171-E6F8-4AC0-A17F-E6FC18DDBF2D Q26798241-1F22D113-D27F-4B1B-BAD1-1E7446AFD656 Q26828564-A5DB8BEA-C0CE-4462-BF1C-B8D20203D776 Q27021467-F9666027-5500-47BF-BB1F-E93B53FA45F3 Q27022958-C087AB3B-7F32-4006-95EB-F0E021904FD7 Q30435843-964DD772-070A-4D6E-BCD3-242FC1A1EEFC Q30711088-BBA856FE-4231-49B4-A2A1-0C2A993E07B0 Q33614231-9920FAA9-1FBE-4CB8-9132-CC4FDC6FEE7E Q33625345-18338F9D-9475-40DA-B3AC-AAB0CEF38882 Q33837167-B1288DBA-9C24-4BBD-AE01-E699C3112993 Q33874459-254284FA-1A10-46AD-9FCE-755C18CEE93D Q33983943-C30055D9-3D61-45F2-B237-46F929BB7A05 Q34181837-E1E76C8B-8FC5-49C8-B665-8ED5501C7354 Q34515817-1FA8E61C-E1C7-4C2F-A240-D2346DF181B2 Q34557706-A68D0439-D805-4738-ACBC-BDD09140C89D Q34640885-7EEF8716-C8E5-4304-B994-8267C29BF848 Q35001345-998E4630-364E-4CDE-84A2-C066A4465015 Q35122330-D29C3F3F-3609-4D72-9084-E78AE22BA345 Q35169141-3569E343-FFB5-4B9D-BB11-1B1CACD7FD8D Q35190702-745B2807-12EF-4A24-928C-B39E66DB914C Q35330737-697422D2-9413-4433-A7C2-351C53480F88 Q35548200-A0BDE18E-F13E-4165-9FA1-75372E818186 Q35549737-916F349E-4879-4E9F-805D-9B40BE95D237 Q35684146-35ED5214-FFE4-4266-8964-6226A3647DCE Q35740330-3B6B4A9F-B969-400B-B364-A6D89E42E8C7 Q35862776-B2519CE1-AA6A-4C13-BD78-66925D13D4AD Q35886579-0E561DA2-629A-43F9-B4E0-24404C6549EA Q35889371-C7D0ADB9-A96C-4F55-BA73-B9B380F17BBC Q36024493-E93787AA-9813-4626-B5E5-11DA19695A05 Q36100170-A326FF44-A558-472E-9DA9-3F4BEAE32EF6 Q36100305-53A156DA-E525-47FF-8706-27DDA62CD65B Q36234571-4943AE30-EA7B-4D90-A860-1CE0CEBA8723 Q36588313-612FBC25-4685-4927-87B4-5B3BC39E60C2 Q36870889-E708EF1F-B48A-48C8-82FC-59EC07D81908 Q36896252-18AFA737-8505-4FC6-B56A-94C7172B839B Q36905864-E286830D-DFDD-4D87-BA3D-6696D70F7EB3 Q37070398-D6C3D800-AC45-470E-98EC-2FD1070BF4A9 Q37099353-8356997B-AA14-44C3-AC56-73E749460DCD

P2860

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

http://www.wikidata.org/entity/Q48878233

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Combining medications to enhan ...... single-blind randomized study.

@en

Combining medications to enhance depression outcomes

@nl

type

label

Combining medications to enhan ...... single-blind randomized study.

@en

Combining medications to enhance depression outcomes

@nl

prefLabel

Combining medications to enhan ...... single-blind randomized study.

@en

Combining medications to enhance depression outcomes

@nl

P1433

Q48878233-2670C7E3-3A00-48D4-A46E-46A677DAB0AF

P1476

Q48878233-C9D6CB62-73CC-44ED-9988-74667B64E13C

P2093

Q48878233-10270FB7-55CF-4434-A248-F5D649FD4ED7

Q48878233-185415CE-748C-4F5D-AFEF-97CED95D36F4

Q48878233-3E93D85E-71AE-408F-A618-1B58F6E017DF

Q48878233-50043611-0A2D-442A-A15A-C6960CE0785B

Q48878233-7A898D2A-0585-4643-A2EB-BB6F12F2E8E8

Q48878233-87E312DE-48D8-48C3-B15C-414BA7037A03

Q48878233-92F1A40B-E7D5-40AC-8B13-1831E907EA7E

Q48878233-952A417F-7B9A-4F38-B58A-62D4260B83A7

Q48878233-A6B2D630-EF02-44CF-A476-7E1CD12EB531

Q48878233-AD24B1C7-15CD-425E-80A5-CF4B5C9545A5

P304

Q48878233-6969D5BF-AA14-4395-BD32-CC20391D1BD9

P31

Q48878233-F379C1B1-8334-4E2D-A823-6DB552AE3498

P356

Q48878233-2AD3BDCF-38AB-4D8D-896A-9FEF4FBF43E4

P407

Q48878233-2BF94C8B-AF8D-4836-8198-68D14D2CA7A2

P433

Q48878233-969A9808-021E-4947-A896-F9BF26051A64

P478

Q48878233-776E7F79-9AE5-4868-AEA4-9754E3899D03

P50

Q48878233-E5BAF340-6A15-49A3-93B9-5EC9E14511C0

Q48878233-F78CB631-37FE-4481-ACA8-DC26BE738FC8

P577

Q48878233-9C93413E-E4BB-4E03-9B86-6CC5F03BA0DB

P5875

Q48878233-DC213537-2618-45CF-9A91-FDB55278773D

P698

Q48878233-C4D3D7F1-E2F1-4414-A575-79CD6C7839CD

P356

APPI.AJP.2011.10111645

P1433

American Journal of Psychiatry

P1476

Combining medications to enhan ...... single-blind randomized study

@en

P2093

Andrew A Nierenberg

http://www.w3.org/2001/XMLSchema#string

Benji T Kurian

http://www.w3.org/2001/XMLSchema#string

David W Morris

http://www.w3.org/2001/XMLSchema#string

Diane Warden

http://www.w3.org/2001/XMLSchema#string

Ian A Cook

http://www.w3.org/2001/XMLSchema#string

Ira M Lesser

http://www.w3.org/2001/XMLSchema#string

James F Luther

http://www.w3.org/2001/XMLSchema#string

Jonathan W Stewart

http://www.w3.org/2001/XMLSchema#string

Madhukar H Trivedi

http://www.w3.org/2001/XMLSchema#string

Maurizio Fava

http://www.w3.org/2001/XMLSchema#string

P304

689-701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.2011.10111645

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Augustus John Rush

Stephen R. Wisniewski

P577

2011-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51092727

http://www.w3.org/2001/XMLSchema#string

P698

21536692

http://www.w3.org/2001/XMLSchema#string